Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-22

FDA Approved: TADALAFIL — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' supplemental application for tadalafil, updating the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)